How peak cough flow and cough augmentation techniques
correlate with respiratory outcomes and quality of life
in
neuromuscular patients
Chief Investigator
Dr Ema Swingwood
Institution
University Hospitals Bristol NHS Trust
Dates
06/02/2017 to 15/05/2017
Funding Stream
RCF Autumn 2016
Amount
£7,874
Summary
Neuromuscular disease is an umbrella term that covers multiple
diseases. It results in muscle weakness, which may affect a
person's breathing and therefore may make a person's cough weaker.
Cough is an essential defence mechanism used to clear mucus from
the lungs and airways. Patients with neuromuscular disease
can get more frequent chest infections, regular and prolonged
hospital admissions and a reduced quality of life.
Treatment techniques that help to strengthen cough are really
important for this patient group. Less frequent infections, and
shorter and less frequent hospital admissions can contribute to an
improved quality of life and additionally reduced cost for the
healthcare provider.
Mechanical insufflation-exsufflation (MI-E) is one such cough
treatment used by Physiotherapists in this patient group. The
machine works by giving the patient a big breath in, which is then
quickly followed by a big sucking breath out. To date research has
focused on the use of this device in the prevention of respiratory
infections. There are gaps in the literature regarding the most
effective set up of the device. Furthermore recent NICE Guidelines
have highlighted a lack of information regarding the cost
effectiveness for the use of this device in the neuromuscular
patient group.